Category Archives: Myocardial Infarction

Jaya Mallidi, MD, MHS We are in the midst of a pandemic. Continue reading →

In February 2020, the American College of Cardiology (ACC) released a clinical bulletin to address early cardiac implications of the current novel coronavirus epidemic, COVID-19 (coronavirus disease 2019).[1,2] The guidance is based on case reports as well as provides information on the potential cardiac implications from analog viral respiratory pandemics and offers early clinical guidance given current COVID-19 uncertainty." Because viral infections such as influenza can destabilize and worsen cardiac conditions, it is likely that COVID-19 will also have an effect, with varying severity in individuals, particularly given indications that 40% of patients with COVID-19 have underlying cardiovascular or cerebrovascular disease.[1,2] These patients are at high risk of having complications and/or dying. COVID-19-related cardiac complications include arrhythmia and acute cardiac injury Continue reading →

OBJECTIVE: A score to distinguish Takotsubo syndrome (TS) from acute coronary syndrome would be useful to facilitate appropriate patient investigation and management. This study sought to derive and validate a simple score using demographic, clinical and ECG data to distinguish women with non-ST elevationmyocardial infarction(NSTEMI) from NSTE-TS Continue reading →

BACKGROUND: To describe age differences in patients chief complaint related to a firstmyocardial infarction, and how the typicality of patients acute symptoms relates to extent of pre-hospital delay. The medical records of 2,586 central Massachusetts residents hospitalized at 11 greater Worcester medical centers with a firstmyocardial infarctionon a biennial basis between 2001 and 2011 were reviewed. Continue reading →

OBJECTIVES: The primary objective was to examine the association between hyperlipidaemia (HLP) and 5-year survival after incident acutemyocardial infarction(AMI). Continue reading →

BACKGROUND: The evolution and clinical impact of cardiac remodeling after large ST-elevationmyocardial infarction(STEMI) is not well delineated in the current therapeutic era. The PRESERVATION I trial longitudinally assessed cardiac structure and function in STEMI patients receiving primary percutaneous coronary intervention (PCI). Continue reading →

BACKGROUND: Owing to reduced staffing, patients hospitalized for acutemyocardial infarction(AMI) during off-hours (nights, weekends, and holidays) have poorer outcomes than those admitted during regular hours. Continue reading →

Aberjona Rehabilitation and Nursing Center, Winchester, is among the most experienced Nursing Homes in handling Heart Attack patients in Massachusetts Want a Demo of Dexur's full capabilities? By: Sruthy Iype &nbspMar. Continue reading →

BACKGROUND: The aim of this systematic review and meta-analysis was to assess the effect of anesthesia maintenance with volatile agents compared with propofol on both short- and long-term mortality (primary outcomes) and major clinical events in adults undergoing cardiac surgery with cardiopulmonary bypass. Randomized clinical trials on the effects of current volatile anesthetics versus propofol in adults undergoing cardiac surgery with cardiopulmonary bypass were searched (1965 to September 30, 2019) in PubMed, the Cochrane Library, and article reference lists Continue reading →

The occurrence of cardiac events in a cohort of patients with HIV was significantly higher in patients treated with tenofovir-alafenamide (TAF) compared with those treated with tenofovir disoproxil fumarate (TDF) or non-tenofovir regimens, according to study results presented at the virtual Conference on Retroviruses and Opportunistic Infections, held from March 8 to 11, 2020. In this retrospective cohort study, researchers studied all cardiac events in patients with HIV (N=2985) from January 1, 2016, to May 31, 2018 Continue reading →